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10 ABSTRACT
Background: Chronic obstructive pulmonary disease (COPD) is a major consumer of healthcare
resources, with most costs related to disease exacerbations. Telemonitoring of patients with COPD
may help to reduce the number of exacerbations and/or the related costs. On the other hand, home
hospitalization is a cost-saving alternative to inpatient hospitalization associated with increased comfort
15 for patients. The results are reported regarding using telemonitoring and home hospitalization for the
management of patients with COPD.
Methods: Twenty-eight patients monitored their health parameters at home for six months. A nurse
remotely revised the collected parameters and followed the patients as programmed. A home care unit
was dispatched to the patients’ home if an alarm signal was detected. The outcomes were compared to
20 historical data from the same patients.
Results: The number of COPD exacerbations during the study period did not reduce but the number of
hospital admissions decreased by 60% and the number of emergency room visits by 38%. On average,
costs related to utilization of healthcare resources were reduced by €1,860.80 per patient per year.
Conclusions: Telemonitoring of patients with COPD combined with home hospitalization may allow for
25 a reduction in healthcare costs, although its usefulness in preventing exacerbations is still unclear.AQ4 �
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Telemonitoring is a patient management approach that uses
communication technology to monitor health status at dis-
tance. In the recent years, its use has increased dramatically,
30 fueled by a rampant technological progress, and has gained a
growing interest as a tool to remotely follow patients with
chronic diseases. Among its potential benefits are improved
patient-doctor communication, increased patient’s autonomy,
reduced hospitalization rate, lower costs for the healthcare
35 system, easier control of patients living in remote areas, and
possible early detection of disease exacerbations [1–4]. Not all
the authors, however, find telemonitoring advantageous [5],
and some even indicate that it may harm doctor-patient rela-
tionship or result in over-treatment [6].
40 Various schemes of telemonitoring have been described:
multiple available methodologies and technologies can be
used alone or in combination [1]. Telemonitoring using elec-
tronic devices can be combined with regular or on-demand
phone interviews. In general, the patient monitors his/her
45 health parameters at home using electronic devices, and the
data are transmitted to the health care center. The data to be
collected can vary from a symptom diary filled out on a touch
screen to clinical parameters measured with electronic
devices. The data can be transmitted automatically by the
50measuring/registering device itself or by the patient via
phone or internet. In some models, the data are received
and revised regularly by a nurse or a doctor who intervene if
an alarm signal is detected. In other models, the data are
collected via a call center, which detects abnormal values
55and informs the health care professional in charge. Whatever
the model used, telemonitoring in itself only allows for timely
detection of alarm signals, upon which an action is required.
The action can vary from self-administration of rescue medica-
tion according to physician’s indications to patient’s visit to a
60hospital or an emergency room. Thus, telemonitoring alone
cannot provide comprehensive health care and fully abolish
the need for intervention by health care professionals or
hospitalization.
Home hospitalization is another strategy that allows to reduce
65health care costs by shortening hospital stay and/or avoiding
hospital admission [7]. In this care scheme, doctors/nurses travel
to patients’ home where they provide acute or subacute care.
Home hospitalization helps to increase patients’ physical and
psychological comfort and reduce the risk of nosocomial infec-
70tions while maintaining high standards of care. Nevertheless, the
lack of constant proximity of and observation by the hospital
staff may lead to a failure to detect early alarm signs and may
result in an emergency room visit.
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Chronic obstructive pulmonary disease (COPD) represents a
75 huge economic burden for the healthcare system worldwide.
Telemonitoring has been proposed as means both to improve
patient’s clinical outcomes and quality of life and to allow for
cost reduction. Results from several studies indicate that tele-
care could help to detect early signs of disease exacerbations
80 and to reduce the need for hospitalization, thereby producing
a saving for the health care system [2,3]. In the same way,
some studies have shown that nurse-centered teleassistance
allows for a reduction in hospital admissions [8,9], and visits to
the emergency department [10]. On the other hand, some
85 studies evaluated the outcomes of home hospitalization dur-
ing COPD exacerbations [11,12] and found that it was asso-
ciated with higher comfort for the patients, savings for the
healthcare system and similar clinical outcomes, compared to
conventional inpatient hospitalization. To our knowledge, to
90 date there have been no studies on combining telemonitoring
and home hospitalization as a COPD management approach.
The objective of the present study was to evaluate the
usefulness of a combined strategy based on telemonitoring
and home hospitalization in reducing the number of hospital
95 admissions and emergency room visits in patients with COPD.
2. Patients and methods
2.1. Study design
This was a single-arm prospective unicenter study that com-
pared the results of applying the telemonitoring and home
100 hospitalization strategy during the study period with the his-
torical results of the same patients.
The study was carried out between February and
September of 2013. All the patients were enrolled within
2 months and were followed for 6 months (study period).
105 The outcomes were compared to the data from the same
months during the previous year, to minimize confounding
due to seasonal variation. The data for the control period were
collected retrospectively from patients’ medical records.
The selection process was based on the revision of the
110 medical records of patients diagnosed with COPD and perso-
nal interview. The sample size was estimated based on feasi-
bility (28 monitoring systems were available).
2.2. Human resources
The home care unit (HCU) was composed of two physicians
115 (an internist and a geriatrist), four nurses, and one nurse
supervisor. During the week, the physicians carried out their
usual work at the hospital between 8.00 and 15.30. On week-
ends and non-working days, the physicians were on calls
between 8.00 and 21.00. The standard working day of the
120 nurses was from 8.00 till 21.00 on any day of the year. In
case of emergency, the patients could call the hospital guard
at night. The hospital reference population was 118,000 inha-
bitants, and the HCU could attend a maximum of 21 patients
per day. For the purposes of the study, a specifically assigned
125 nurse dedicated 8 h per week to data monitoring and patient
follow-up. The nursing staff did not have a specific certified
training in pneumology. However, there were nurses
specifically devoted to respiratory diseases who could be con-
sulted by the nurse in charge of monitoring in case of need.
130This latter nurse could also consult with the physician specia-
lized in pneumology. The pulmonologist participated in
patient selection and visited the study patients in outpatient
clinic with the usual frequency. No other additional human
resources were involved.
1352.3. Technological resources
Electronic devices were used to measure heart rate, blood
pressure, and peripheral oxygen saturation. The devices were
connected to a communication hub via Bluetooth. The hub
contained a SIM card and was continuously connected to an
140electricity source via a conventional wall plug. The data were
automatically transmitted to the administration web platform
where they could be consulted by the study team from any
device with internet connection. When the obtained values
were outside the normal range, the telemonitoring system
145generated an alarm signal that was sent to the smartphone
of the nurse in charge of telemonitoring or, in case of her
unavailability, to the study physicians; the values were also
registered in the web platform. As a general rule, an alert was
activated for all patients with an O2 saturation <92% (regard-
150less of the use of chronic oxygen therapy), heart rate > 100
bpm or < 60 bpm, and systolic blood pressure > 140 mmHg,
but normal ranges could be personalized to fit clinical char-
acteristics of each patient. Patients were instructed to measure
the parameters once a day and each time they presented
155respiratory symptoms. All technological support was provided
by Cystelcom Sistemas S.A. (Madrid, Spain).
The participants received face-to-face instructions on cor-
rect use of the measuring devices. A study team nurse visited
the patients in their home to confirm the correct assimilation
160of the instructions. In case of technical issues the patients
could contact the provider of the electronic devices.
2.4. Description of intervention
Telemonitoring program consisted of two strategies: follow-up
and control by a nurse during the stable phase and interven-
165tion by the HCU team during disease exacerbations. During
the stable phase, the nurse in charge revised the data col-
lected in the web platform every working day, carried out a
structured phone interview with every patient once a week
and visited the patients in their home once a month. At each
170scheduled visit, nurses assessed the inhalation technique and
made recommendations on lifestyle. In addition, the nurse
called the patients when an out-of-range value was received.
The patients could also contact the nurse telephonically.
During visits or phone calls the nurse could make thera-
175peutic recommendations, that is, on the use of bronchodila-
tors, mucolytics, and respiratory physiotherapy. Patients who
felt worse in the evening or in the night on a week day or
during the weekend were instructed to go to the hospital
emergency room where they were identified as the study
180participants, and their visits were registered. Patients were
instructed to contact their primary care physician for any
health problems unrelated to respiratory symptoms.
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When an out-of-range value was received in the web plat-
form (or after a clinical worsening reported by the patient over
185 the phone, even if no alarm was detected), the monitoring
nurse administered a symptoms questionnaire over the phone
(Figure 1). That means that oxygen saturation was evaluated
as an additional parameter within the patient’s clinical picture
along with other signs and symptoms of COPD exacerbations
190 (dyspnea, sputum volume and purulence, axillary tempera-
ture). Therefore, if an isolated and non-significant fall in oxy-
gen saturation was detected, no specific recommendations
were given, although a follow-up was implemented to detect
the appearance of new symptoms. A COPD exacerbation was
195 defined as a ‘sustained worsening of the patient’s condition,
from the stable state and beyond normal day-to-day variations
that is acute in onset and may warrant additional treatment in
a patient with underlying COPD’.
Any COPD exacerbation detected through the question-
200 naire was reported by the nurse to the doctor (an internist
or geriatrist) at the home hospitalization unit. Then, it was
these doctors who made the decision to either refer the
patient to her/his health center to be followed by her/his
primary care physician; order daily check-ups by the nurse at
205 the telemonitoring center; carry out a home-based assess-
ment; create an episode of home hospitalization; or transfer
the patient to the Emergency Department if symptoms were
severe. Both the indications and the management of patients
in hospital at home during the control period were the same
210 as during the study period.
Exclusion criteria for admission in the HCU were: deteriora-
tion of consciousness, acute confusional state, new-onset cya-
nosis or severe dyspnea with use of accessory muscles, arterial
pH < 7.35 on arterial blood gas analysis (if this was done),
215 acute changes on chest-X ray, acute EKG changes, if an EKG
was performed, and concomitant medical disorders requiring
hospitalization. No specific criteria were defined neither for
referral of the patient to her/his primary care physician nor for
the decision to refer the patient to the emergency department
220that were not the impossibility of visiting the patient immedi-
ately in case of seriousness or that the patient themselves
voluntarily expressed the desire to go to the emergency
department.
Patients who were eventually hospitalized at home
225received standard care provided by the HCU. The measure-
ments and data collection/transmission were identical during
the acute and the stable phase, but during the acute phase
the data were analyzed by the HCU personnel.
2.5. Study population
230The inclusion criteria were: patients with spirometry-confirmed
diagnosis of COPD; at least two hospital admissions or one
hospital admission and two or more emergency room visits
due to a COPD exacerbation during the 12 months prior to the
inclusion in the study; residency in the geographic area cov-
235ered by the HCU; home condition adequate for carrying out
clinical practice, and availability of a caregiver 24 h per day.
The exclusion criteria were: diagnosis of asthma or another
respiratory disease different from COPD; end-stage COPD; his-
tory of lung volume reduction surgery or lung transplant;
240tracheostomy; any serious comorbidity that could interfere
with the study and cause life expectancy < 6 months; signifi-
cant functional dependency (Barthel index [13,14] value < 15);
severe cognitive impairment (Short Portable Mental Status
Questionnaire [15] score > 8); poor treatment adherence;
245patient’s or caregiver’s incapacity to use the study devices,
and participation in a another clinical trial.
Withdrawal criteria were: serious adverse events; protocol
deviations that could affect the validity of the results, and
consent withdrawal.
2502.6. Study endpoints
Primary endpoints were incidence and mean duration of hos-
pital admissions and incidence of emergency room visits. In
addition, the following data were collected and analyzed:
demographic data (age, gender), clinical data (COPD severity,
255use of long-term oxygen therapy; body mass index); use of
other healthcare resources (primary care visits; hospitalization
in intensive care units); healthcare costs of acute episodes;
patient-perceived quality of care and user’s and technical
evaluation of the telemonitoring system. At the beginning
260and at the end of the study period we collected data from
Charlson comorbidity index [16]; performance in activities of
daily living as measured by Barthel index; the modified
Medical Research Council breathlessness scale score [17,18];
health-related quality of life as measured by COPD assessment
265test [19]; and the body mass index. Rates to calculate costs
were taken from a publication by the Galician Health Service
[20]. These figures were used because this was the only refer-
ence data available at the time the manuscript was written.
The prices shown include all those costs likely to be incurred
270by a home hospitalization unit (personnel, drugs/medicines,
transportation, etc.). A 10-item ad-hoc questionnaire, with
each item rated as ‘I agree’ or ‘I disagree’, was developed for
the evaluation of the patient-perceived quality of care. This
Score
SYMPTOM QUESTIONNAIRE
I am more breathless than usual* ____________
My sputum has increased in color* ____________
My sputum has increased in amount* ____________
I have a cold (such as runny or blocked nose) ____________
I have increased chest tightness or wheezing ____________
I have a sore throat ____________
I have an increased cough ____________
I have a fever ____________
TOTAL ____________
*These three symptoms score 2 points. 
The other symptoms score 1 point.
Symptom score < 4. No action
Symptom sore = 4. Phone call the next day
- Score < 4. No action
- Score = 4. Home visit
- Score > 4. Referral to home hospitalization physicians
Symptom score > = 5. Referral to home hospitalization physicians
Figure 1. Symptom questionnaire and intervention protocol.
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questionnaire is not validated, although it is similar to those
275 used in other studies. The questions were designed based on
those aspects the investigators considered to be more rele-
vant to analyze the results.
2.7. Ethical conduct of the research
The study was designed and carried out in agreement with the
280 Declaration of Helsinki. The study protocol was approved by the
Ethics Committee of University Hospital of Torrejon. All the
patients signed an informed consent prior to being included in
the study.
2.8. Statistical analysis
285 No formal calculation of sample size was performed; the num-
ber of patients was defined based on feasibility. Non-parame-
trical tests were used for statistical analysis. The differences
between the intervention and the control periods were
assessed using Wilcoxon signed-rank test for continuous vari-
290 ables and McNemar test for categorical variables. Data from
the two patients who died during the study were included in
the analysis; for these patients, the calendar period from the
previous year equivalent to the period of their participation
(from enrolment to study termination) was used as control.
295 2.9. Study funding
Cystelcom Sistemas S.A. assumed the costs of the technology
(devices, internet connection). Funds from the University




Twenty-eight patients were enrolled in the study. Twenty-six
patients completed the 6-month telemonitoring period. Two
patients died during the study: one died in the intensive care
305 unit from a septic shock that originated from a community-
acquired pneumonia, and the other died during a conven-
tional hospitalization from respiratory and multiple organ fail-
ure secondary to a community-acquired pneumonia. Neither
patient was being cared by the home hospitalization unit at
310 the time of onset of respiratory symptoms.
3.2. Baseline characteristics
Most patients (26/28) were males, and the mean age was
78 years (range 58–96 years; standard deviation
[SD] = 7.9 years). The mean baseline FEV1 was 50.8% (range
315 28–80%; SD = 18.3). During the study two patients were active
smokers. Baseline clinical and demographic characteristics are
shown in Table 1.
3.3. Effectiveness of the intervention
Clinical characteristics of the patients did not change signifi-
320cantly from baseline to end of study, except for Charlson
comorbidity index, which raised from 3.4 points at baseline
to 4.4 points at final visit (p < 0.05), and Barthel performance
index, which diminished from 78.5 to 73.8 points (p = 0.02).
A total of 72 exacerbation episodes were registered in a
325total of 25 (89.3%) patients during the study period (mean:
2.6 episodes per patient), versus 59 exacerbations in 26
(92.9%) patients during the control period (mean: 2.1 epi-
sodes per patient; p = 0.21). It can be seen that the number
of patients included in the study were 28, however, only 26
330had exacerbations during the control period. These findings
can be explained because the inclusion of patients was
based on the exacerbations (two hospital admissions or
one admission plus two or more visits to the Emergency
Department) occurring throughout a whole year (2012).
335However, the control period with which the study period
was compared lasted only 6 months for each patient. In
other words, some patients may have had exacerbations
during year 2012 out of the control period, although these
exacerbations could have been used as inclusion criteria for
340the study patients.
Activities of the telemonitoring nurse and the HCU per-
formed during the study are summarized in Table 2. The
most common actions performed by the telemonitoring
nurse were programmed calls (n = 589), programmed visits
345to patients’ homes (n = 159), and therapeutic recommenda-
tions, especially on physiotherapy (n = 236). These recommen-
dations were made by the telemonitoring nurse whenever the
patient experienced an increased sputum volume or dyspnea,
but with no other symptoms of serious or infectious exacer-
350bation, such as fever or increased sputum purulence. These
recommendations were provided over the phone, and a daily
follow-up was implemented to assess whether clinical mani-
festations remitted o worsened. The only physical therapy
resource recommended was the use of an incentive spirom-
355eter to facilitate expectoration. Scheduled visits were per-
formed as per calendar, and were independent of patients’
Table 1. Patients’ clinical and demographic characteristics.
Baseline (n = 28) 6 months (n = 26)
p
value
Males, n (%) 26 (93)
Age (years), mean (SD) 78 (7.9)
COPD Severity, n (%)
GOLD I 1 (3.6)
GOLD II 14 (50)
GOLD III 10 (35.7)
GOLD IV 3 (10.7)
LTOT, n (%) 11 (39)
Charlson comorbidity score,
mean (SD)
3.4 (1.4) 4.4 (1.8) <0.05
Barthel index, mean (SD) 78.5 (22.8) 73.8 (31.9) 0.02
Body mass index, mean (SD) 28.6 (5.6) 28.3 (5.1) 0.5
Modified breathlessness MRC
score, mean (SD)
2.9 (0.8) 2.8 (0.8) 0.2
CAT score, mean (SD) 21.6 (4.9) 20.7 (5.2) 0.08
SD: standard deviation; CAT: chronic obstructive pulmonary disease assessment
test; MRC: Medical Research Council; COPD: chronic obstructive pulmonary
disease; GOLD: global initiative for chronic obstructive lung disease; LTOT:
long-term oxygen therapy.
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clinical course. The most frequent referrals were to hospital at
home (n = 32). Not all patients with exacerbation of COPD
admitted to home hospitalization did so at the request of the
360 nurse in charge of telemonitoring. Some were referred from
the Emergency Department and others had previously gone
through conventional hospitalization. That is why not all home
hospitalization admissions during the study period (n = 57)
were performed at the request of the monitoring nurse.
365 Utilization of healthcare resources during the study and the
control periods is summarized in Table 3. In relation to EPOC,
healthcare resources were used on 110 occasions during the
study period and on 110 occasions during the control period.
Thirteen conventional hospital admissions occurred during the
370 study period (mean: 0.46 admissions per patient; range 0–4),
compared with 33 hospital admissions during the control
period (mean: 1.18 admission per patient; range 0–4;
p = 0.0067 vs study period), which means a reduction of
60% during the intervention period. The number of admitted
375 patients was 21 (75.0%) during the control period and 7
(25.0%) during the study period. There was a 58% reduction
in the total number of days spent in the hospital, from
212 days during the control period to 89 days during the
study period. The average length of conventional hospitaliza-
380 tion was similar during both periods: 6.84 days (range: 3–10)
during the study period, and 6.42 days (range: 2–39) during
the control period (p = 0.82). The number of visits to emer-
gency room decreased by 38%, from 53 visits during the
control period (in 26 (92.9%) patients; mean 1.89 visits/patient;
385range 0–6) to 33 visits during the telemonitoring period (in 15
(53.6%) patients; mean 1.18 visits/patient; range 0–6, p = 0.03).
In general, fewer patients had to be admitted to the
hospital or to go to emergency room during the telemoni-
toring period: only 15 patients (53.6%) had to stay in hos-
390pital or present in the emergency room during the study
period, compared to 26 (92.8%) patients during the control
period (RR 0,58; IC 95% 0,40 – 0,83 p = 0.002). Such reduc-
tion translated into higher number of home hospitalizations,
which occurred on 57 occasions during the study period (in
39523 (82.1%) patients; mean: 2.04 home hospitalizations per
patient, range: 0–7) versus 12 occasions during the control
period (in 8 (28.6%) patients; mean: 0.4 home hospitaliza-
tions per patient, range: 0–4; p < 0.001). The average dura-
tion of home hospitalizations was similar between the two
400periods (9.6 days, range: 0–26 days during the study period,
and 11.4 days, range: 5–22 days during the control period,
p = 0.31).
3.4. Costs of utilization of healthcare resources during
control and telemonitoring periods
405We analyzed the costs of utilization of healthcare resources
during the control and the telemonitoring periods, using refer-
ence prices for each type of resource (Table 4). Reference costs
of bed per day were used for calculating the total costs of in-
patient hospitalization, home hospitalization and ICU stays.
410Overall, telemonitoring combined with home hospitalization
was associated with reduced costs related healthcare resource
utilization (an estimated total of 116,274.50 € during the study
period versus 142,325.8 € during the control period).
3.5. Patient-perceived quality of care and technology
415acceptance
Thirteen patients (11 males and 2 females, mean age 75.4 years,
range 58–84) completed the ad-hoc satisfaction questionnaire.
The results are shown in Figure 2. The degree of satisfaction was
high (at least 77%) for all items covered by the questionnaire.
420The patients were also asked how much time they had to invest
into learning how to use the technology. Six (46%) patients
Table 2. Actions performed by the telemonitoring nurse (autonomously or after
consulting the HCU physicians) and by the HCU during the study period.
Actions N
Actions performed by the telemonitoring nurse
Visits and phone calls Programmed visits 159
Emergency visits 20
Programmed phone calls 589
Not programmed phone calls 52
Phone call received from patients 77
Referrals to Primary care 24
Pneumologist (outpatient office) 5
Other specialists (outpatient office) 5
COPD-related home hospitalization 32
Therapeutic recommendations Use of bronchodilators 81
Use of mucolytics 51
Physiotherapy 236
Actions performed by the HCU




COPD: chronic obstructive pulmonary disease; HCU: home care unit.
Table 3. Utilization of healthcare resources during the study and the control periods.




(n = 28) p
Hospital admission, n 13 33
Emergency room visit, n 33 53
Home hospitalization, n 57 12
Primary care visit, n 5 12
Admission to intensive care unit, n 2 0
Total 110 110
Hospital admission episodes per patient, mean (range) 0.46 (0–4) 1.18 (0–4) 0.006
Emergency room visit per patient, mean (range) 1.18 (0–6) 1.89 (0–6) 0.03
Home hospitalization episodes per patient, mean (range) 2.04 (0–7) 0.4 (0–4) < 0.001
Primary care visit per patient, mean (range) 0.18 (0–1) 0.43 (0–3) 0.114
Hospital LOS mean (range) 6.84 (3–10) 6.42 (2–39) 0.82
Home hospitalization LOS mean (range) 9.6 (0–26) 11.4 (5–22) 0.31
LOS: length of stay; SD: standard deviation.
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invested one day or less, four (31%) patients invested more than
one day but less than one week, and three (23%) patients
invested between one and two weeks. We did not evaluate
425 the caregiver burden, although we did not receive any com-
plaint during the study period regarding frequency of assess-
ments (phone calls and scheduled visits) or the recording of
clinical parameters (at least once daily).
3.6. Technical evaluation of the telemonitoring system
430 Twenty-eight technical incidents were registered during the
study. The most frequent event (n = 14) was an erroneous
perception by the patient that the device was malfunctioning.
Other incidents included suboptimal internet connection
(n = 5), malfunctioning of communication devices (n = 4),
435 battery replacement (n = 4), and device breakage (n = 1).
4. Discussion
The results of the present non-randomized single-arm inter-
ventional study demonstrate that using telemonitoring and
home hospitalization for management of patients with COPD
440may reduce the number of hospital admissions and emer-
gency room visits and to diminish the costs related to health-
care resource utilization.
In theory, close monitoring of clinical parameters might
allow for early detection of symptom deterioration and
445timely intervention, thus preventing a fully blown exacer-
bation. Indeed, several randomized controlled studies indi-
cate that this may be the case [21,22]. In our study,
however, the studied approach did not lead to reduction
in the number of exacerbations. Several reasons may con-
450tribute to this inconsistence. First, use of historical control
could be associated with data loss and underestimation of
real number of exacerbation during the control period.
Second, COPD is a progressive disease, and most partici-
pants were seriously ill, of advanced age and with a sig-
455nificant comorbidity burden; their health may have
declined during the months separating the control and
the study period. Finally, this inconsistence could be due
to differences in the telemonitoring approach and the
standard care across the studies.
460In our study, the combined strategy of telemonitoring and
home hospitalization in patients with COPD helped to reduce
Table 4. COPD-related costs of healthcare resources utilized during the study and the control periods.
Type of healthcare resource






Total costs per type of
resource
Study period (n = 28)
Hospital admission 13 (25.0) 89 526.00 € 3601,08 € 46,814.00 €
Emergency room visit 33 (53.6) - - 359.00 € 11,847.00 €
Home hospitalization 57 (82.1) 547 80.00 € 767.71 € 43,760.00 €
Primary care visit 5 (17.9) - - 68.90 € 344.50 €
Admission to intensive care unit 2 (7.1) 7 1,136.00 € 3,976.00 € 7,952.00 €
Telemonitoring nurse (8h/week during
32 weeks)
5.557,00 €
Total costs during study period
116,274.50 €
Control period (n = 28)
Hospital admission 33 (75.0) 212 526.00 € 3,379.15 € 111,512.00 €
Emergency room visit 53 (92.7) – 359.00 € 19,027.00 €
Home hospitalization 12 (28.6) 137 80.00 € 913.33€ 10,960.00 €
Primary care visit 12 (32.4) – 68.90 € 826.80 €
Admission to intensive care unit 0 0 1,136.00 € 0 € 0 €
Total costs during control period
142,325.8 €
aPercentage of patients who used the given healthcare resource
Figure 2. Patient-perceived quality of care and technology acceptance.
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the number of conventional inpatient hospitalizations by 60%,
compared to the control period in the previous year in the
same group of patients. Several previous studies focusing on
465 telemonitoring alone also reported a reduction in the number
of hospital admission in patients with COPD followed via
telemonitoring, but the effect was smaller. Thus, in a recent
randomized controlled trial, Pedone et al. [22] found that the
number of hospital admissions in the telemonitoring group
470 was 33% lower than in the control group that received stan-
dard care. Other randomized studies reported a reduction of
32%–46% in the number of hospital admissions [21,23]. It
seems that in our case the combination of telemonitoring
with home care unit implication permitted to treat most
475 exacerbations in the patients’ home, without the need for
inpatient hospitalization.
It should be noted that during the study, the nurse in
charge of the monitoring performed the control of the
patients only on weekdays and during the day. In case of
480 symptom worsening on weekends, holidays and at night,
patients were instructed to contact the emergency services.
Therefore, we believe that providing telemonitoring services
during the night and on weekends may have allowed to avoid
a few further hospital admissions and emergency department
485 visits during the study period.
When the hospitalization did occur during the study period,
the length of hospital stay was similar to the one during the
control period. In contrast, some other studies reported short-
ening of hospital stay associated with telemonitoring [24]: thus,
490 in the randomized controlled study by Bourbeau et al. [21], the
average length of hospital stay was shorter in the group receiv-
ing telephonic support, compared to the standard care group
(7.2 ± 19.5 versus 12.5 ± 21.2 days), similar to the study by Lewis
et al. (7.43 ± 15.6 versus 18.2 ± 24.55 days). However, other
495 studies did not find shortening of hospital stay in telemonitor-
ing groups [2] or even showed the opposite effect [25].
In agreement with previous reports [23], the number of
emergency room visits in our study was reduced by 38%,
compared to the control period.
500 In a recent observational, controlled study, the interven-
tion group (telemonitoring and education provision on
COPD) showed a reduction, as compared to the usual care
group, in the number of hospital admissions (OR 0.38 95% CI
0.27–0.54; p < 0.0001), emergency department visits (OR
505 0.56 95% CI 0.35–0.92; p < 0.02), readmissions within
30 days of discharge (OR 0.46 95% CI 0.29–0.74; p < 0.001),
and cumulative length of hospital stay (OR 0.58 95% CI 0.46–
0.73; p < 0.0001) over a two-year follow-up period [26]. The
reduction rates of admissions and emergency department
510 visits are similar to those observed in our study, although
duration of follow-up was 6 months in our study, the period
during which the technology-supplying company provided
us with both the devices and the platform for telemonitor-
ing. Longer follow-up periods would be necessary to check if
515 the reduction in the number of admissions and emergency
department visits is maintained.
As expected, fewer visits to emergency room and inpatient
hospitalizations translated into a higher number of home
hospitalizations (57 home hospitalizations during study period
520versus 12 during the control period). Moreover, the average
length of home hospitalization during the study was similar to
the control period. We do not have a definite explanation for
this finding. It might well be that, although remote monitoring
did allow for a better knowledge of a patient’s status at any
525moment, it did not result in a shortening of treatment periods.
We do not know if, because of disease progression, the exacer-
bations observed during the interval between the control
period and the study period were more serious and required
more days of control and follow-up. Therefore, this is an
530aspect that we should consider for future studies.
The Charlson index increased 1 point in only six months. It
might be due to some patients being diagnosed of highly
prevalent conditions, such as heart failure, cerebrovascular
disease, diabetes mellitus, or diabetic end-organ damage (reti-
535nopathy, nephropathy, neuropathy) during the study period.
Similarly, there was a significant reduction in Barthel’s index,
which could be explained by a COPD progression and/or
increased comorbidity.
In our study, costs related to utilization of healthcare
540resources were reduced, compared to the control period,
producing a saving of 26,051.3 € for 28 patients over 6 months.
This suggests that the described program could produce an
average saving of 1,860.8 € per patient per year. Due to the
devices being given free of charge to the institution where the
545study was done, this calculation does not take into account
the costs of device purchase and monitoring system installa-
tion (capital investment) and costs of technical maintenance,
which can vary substantially. A different result would have
been obtained if these costs had been included; it should be
550mentioned, however, that costs of technology are continu-
ously decreasing, so acquisition of these devices has become
easier. At present, studies evaluating economic effects of tele-
monitoring in COPD are scant, with disparate results and large
variability in methodology. The general trend, however, is that
555telemonitoring has the potential to produce cost reduction for
the healthcare system [2,3]. Some studies even claim that the
initial investment could pay off within the first year of the
program implementation [23]. To our knowledge, there have
been no previous reports on economic benefits of combined
560telemonitoring and home hospitalization in COPD.
In our study, patients showed a high degree of compli-
ance with auto-monitoring program (data not shown), sug-
gesting that use of communication technology is possible in
the described population of patients. In addition, the
565patients demonstrated a high degree of satisfaction with
the telemonitoring program, in agreement with previous
observations [27]. Complaints related to interaction with
technologies were few; however, in our study all patients
had an available caregiver who could help them to use the
570devices correctly. Previous studies underline the importance
of user-friendliness and ease of use of the technology for
higher adherence levels and overall success of telemonitor-
ing programs [1,28].
The present study has several important limitations for the
575interpretation of the results. First, the number of participants was
low, limited by the number of available devices and the restric-
tive selection criteria. Therefore, the results observed might have
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been affected/influenced by the patients not being included
consecutively but rather selected according to predefined cri-
580 teria, and the results may not be generalizable to a larger popu-
lation. Second, this was a non-randomized study without a
control group. Using historical data from the same patients as a
control may be associated with recall bias, data incompleteness
and distortions introduced by the natural evolution of the dis-
585 ease and changes in the health care system. Furthermore, during
the control period (with no monitoring) the patients had access
to the home hospitalization system following the standard cir-
cuits. It may well be that during the study period a greater effort
was made to avoid hospital admission of patients, which could
590 have partly contributed to the lower number of hospitalizations
observed. This is a common limitation of non-randomized inter-
vention studies. Third, the fact of participating in the study could
influence the habits and adherence of the patients, which could
introduce an additional bias in this before-and-after study.
595 In addition, during the study the patients were visited by
the monitoring nurse, who provided recommendations on
various health-related topics (inhalers, lifestyles), which did
not occur in the control period and could also have potential
positive effect on the observed results. Fourth, because of the
600 time restrictions in the lending of telemonitoring devices, the
follow-up period was limited to only six months. A longer
follow-up period could have permitted to see a more pro-
nounced effect of the intervention. Finally, the results of the
satisfaction survey should be taken with caution, since the
605 participants for this study were carefully selected and may
not accurately represent the general population of patients
with COPD. Moreover, the survey format limits the interpreta-
tion of the results, even when these are mostly satisfactory.
Modern technology allows for distant monitoring of various
610 clinical parameters and for exacerbation prediction through
pattern analysis. However, technology should not replace care
given by healthcare professionals, but serve as means to
improve quality and optimize efficiency of care. There will
always be a need for a team of nurses and physicians who
615 would identify and interpret signals and intervene according
to the therapeutic needs of the patient. Home hospitalization,
which uses hospital-level resources and can provide complex
care, can be an efficient and safe alternative to hospital admis-
sion and emergency room visits for many patients with
620 decompensated chronic diseases, such as COPD.
5. Conclusions
Our observations suggest that combination of telemonitoring
and home hospitalization may allow for reduction in the num-
ber of hospital admissions and visits to emergency room, com-
625 pensated by an increased number of home hospitalizations.
Such combined approach may help to reduce the economic
burden of COPD exacerbations for the healthcare system.
Key issues
● Telemonitoring uses communication technology to monitor
630 health status at distance. It is being used increasingly to
remotely follow patients with chronic diseases, including
COPD. Telemonitoring allows for timely detection of alarm
signals, upon which an action by health care professionals
is required.
635● Home hospitalization is a cost-saving alternative to inpati-
ent hospitalization associated with increased patients’ com-
fort and reduced risk of nosocomial infections.
Nevertheless, the lack of constant proximity of and observa-
tion by the hospital staff may lead to a failure to detect
640early alarm signs.
● In this study, we evaluated the usefulness of a combined
strategy based on telemonitoring and home hospitalization
in reducing the number of hospital admissions and emer-
gency room visits in patients with COPD.
645● Twenty-eight patients with COPD (93% males, mean age
78 years, mean baseline FEV1 50.8%, 39% using long-term
oxygen therapy) monitored their health parameters at
home using measuring devices connected to a web plat-
form during 6 months.
650● A specifically assigned nurse revised the collected parameters
daily and performed programmed and on-demand phone
calls and home visits. A home care unit (an internist and/or
a geriatrist and/or nurses) was dispatched to the patients’
home in case an alarm signal was detected. The outcomes
655were compared to historical data from the same patients.
● A total of 72 exacerbation episodes were registered in a
total of 25 (89.3%) patients during the study period (mean:
2.6 episodes per patient), versus 59 exacerbations in 26
(92.9%) patients during the control period (mean: 2.1 epi-
660sodes per patient; p = 0.21).
● The number of conventional hospital admissions was
reduced by 60% during the telemonitoring period (a total
of 13 admission versus 33 admissions in the control period),
whereas the number of visits to emergency room
665decreased by 38%, from 53 visits during the control period
to 33 visits during the telemonitoring period. Such reduc-
tion translated into higher number of home hospitaliza-
tions, which occurred on 57 occasions during the study
period versus 12 occasions during the control period.
670● Telemonitoring combined with home hospitalization was
associated with reduced costs related to healthcare
resource utilization (an estimated average saving of
1,860.8 € per patient per year).
● We conclude that such combined approach may help to
675reduce the costs related to disease management, however,
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